ALNY
Price
$288.06
Change
-$10.70 (-3.58%)
Updated
Jul 13 closing price
Capitalization
38.46B
16 days until earnings call
Intraday BUY SELL Signals
ALPS
Price
$0.50
Change
-$0.05 (-9.09%)
Updated
Jul 13 closing price
Capitalization
84.66M
Intraday BUY SELL Signals
Interact to see
Advertisement

ALNY vs ALPS

ALNY vs ALPS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALNY vs. ALPS commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a StrongBuy and ALPS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (ALNY: $288.06 vs. ALPS: $0.50)
Brand notoriety: ALNY and ALPS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 138% vs. ALPS: 130%
Market capitalization -- ALNY: $38.46B vs. ALPS: $84.66M
ALNY [@Biotechnology] is valued at $38.46B. ALPS’s [@Biotechnology] market capitalization is $84.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileALPS’s FA Score has 1 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • ALPS’s FA Score: 1 green, 4 red.
According to our system of comparison, ALNY is a better buy in the long-term than ALPS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 4 TA indicator(s) are bullish while ALPS’s TA Score has 4 bullish TA indicator(s).

  • ALNY’s TA Score: 4 bullish, 6 bearish.
  • ALPS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ALPS is a better buy in the short-term than ALNY.

Price Growth

ALNY (@Biotechnology) experienced а -7.98% price change this week, while ALPS (@Biotechnology) price change was -14.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

ALNY is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($38.5B) has a higher market cap than ALPS($84.7M). ALNY YTD gains are higher at: -27.559 vs. ALPS (-42.363).
ALNYALPSALNY / ALPS
Capitalization38.5B84.7M45,455%
EBITDA866MN/A-
Gain YTD-27.559-42.36365%
P/E Ratio72.38N/A-
Revenue4.29BN/A-
Total Cash3.01BN/A-
Total Debt1.27BN/A-
FUNDAMENTALS RATINGS
ALNY: Fundamental Ratings
ALNY
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
66
SMR RATING
1..100
13
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALNYALPS
RSI
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
44%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
36%
Momentum
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
21%
MACD
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
15%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
34%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
36%
Advances
ODDS (%)
Bullish Trend 12 days ago
73%
Bullish Trend 12 days ago
53%
Declines
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
70%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
46%
Aroon
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 1 day ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signal:
Gain/Loss:
ALPS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SIM29.84N/A
N/A
Groupo Simec SAB de CV
EMBC3.21-0.03
-0.93%
Embecta Corp
SG8.27-0.09
-1.08%
Sweetgreen
CVNA64.99-0.84
-1.28%
Carvana Co
PASG4.46-0.11
-2.41%
Passage Bio Inc

ALPS and

Correlation & Price change

A.I.dvisor tells us that ALPS and NUVL have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALPS and NUVL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPS
1D Price
Change %
ALPS100%
-9.11%
NUVL - ALPS
21%
Poorly correlated
+0.03%
ALNY - ALPS
17%
Poorly correlated
-3.58%
APLM - ALPS
12%
Poorly correlated
-24.93%
SGMT - ALPS
9%
Poorly correlated
-2.99%
GDTC - ALPS
8%
Poorly correlated
-8.65%
More